aarbisser@kayescholer.com
Los Angeles
T: (310) 788-1015
F: (310) 229-1815
Mr. Arbisser’s practice encompasses a broad range of complex litigations. He has been nationally recognized for his successes in defending pharmaceutical companies in product liability cases and related consumer class actions. In the PPA products liability litigation, co-chaired the PPA joint defense team on experts and science issues, defeated a class action seeking refunds on millions of dollars of product containing PPA that had been withdrawn from the market, won the first-in-the-nation PPA trial, O'Neill, et al. v. Novartis Consumer Health, Inc., JCCP-4166 (L.A. Super. Ct. Jan. 22, 2004), and then successfully argued the appeal from the jury verdict for Novartis Consumer Health, Inc. Both the Daily Journal and the National Law Journal selected this verdict as one of the “Top 10 Verdicts of 2004.” Mr. Arbisser was also recognized as one of California’s leading practitioners in the Antitrust field and is cited in the Who’sWhoLegal: California 2009 publication.
Mr. Arbisser began his career as one of the last proteges of Professor Milton Handler, the founder of the antitrust practice at Kaye Scholer. As an antitrust lawyer, Mr. Arbisser has won cases at both the trial and appellate levels, in both federal and state court, including, in California v. Texaco Inc., convincing the California Supreme Court that the state’s antitrust laws did not apply to a multibillion-dollar merger. He has also successfully defended or resolved numerous antitrust class actions, and counsels clients on a wide range of antitrust, intellectual property and advertising issues.
A frequent lecturer and author, Mr. Arbisser has appeared at many speaking engagements and published numerous articles in the area of antitrust law.